| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/28/2005 | EP1578450A1 Amplification of biotin-mediated targeting |
| 09/28/2005 | EP1578438A1 Synthetic peptide analogs for the treatment of cancer |
| 09/28/2005 | EP1578426A1 Combination of a nitrogen mustard analogue and imatinib for the treatment of chronic lymphocytic leukemia |
| 09/28/2005 | EP1578396A2 Methods and compositions concerning poxviruses and cancer |
| 09/28/2005 | EP1578380A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 09/28/2005 | EP1578369A2 Screening strategy for anticancer drugs |
| 09/28/2005 | EP1578351A2 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders |
| 09/28/2005 | EP1578347A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 09/28/2005 | EP1578346A2 Raf-mek-erk pathway inhibitors to treat cancer |
| 09/28/2005 | EP1578345A2 Peptides and antibodies to muc 1 proteins |
| 09/28/2005 | EP1463731B1 Dibenzodiazepine derivates, their preparation and use |
| 09/28/2005 | EP1401438B1 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors |
| 09/28/2005 | EP1373258B1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 09/28/2005 | EP1366029B1 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolins and the utilization thereof as anticoagulant and antithrombotic agents |
| 09/28/2005 | EP1299365B1 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 09/28/2005 | EP1299103B1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 09/28/2005 | EP1296722B1 Radiotherapy |
| 09/28/2005 | EP1289559B8 Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 09/28/2005 | EP1286987B1 Heterocyclic hydrazones for use as anti-cancer agents |
| 09/28/2005 | EP1274458B1 Compositions containing a naphthalmide and an antiproliferative agent |
| 09/28/2005 | EP1263787B1 G-protein coupled receptor |
| 09/28/2005 | EP1243583B1 Heterocyclic compounds having sulfonamide groups |
| 09/28/2005 | EP1228072B1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 09/28/2005 | EP1210348B1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 09/28/2005 | EP1163227B1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them |
| 09/28/2005 | EP1141006B1 Topoisomerase ii inhibitor |
| 09/28/2005 | EP1135486B1 RECOMBINANT SOLUBLE Fc RECEPTORS |
| 09/28/2005 | EP1093453B1 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 09/28/2005 | EP1086099B1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 09/28/2005 | EP0963200B1 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid |
| 09/28/2005 | EP0944639A4 Synthetic glycoamines, methods for their use that affect cell |
| 09/28/2005 | CN1675363A T-cell epitopes in staphylococcal enterotoxin B |
| 09/28/2005 | CN1675362A HLA-A24-restricted cancer antigen peptide |
| 09/28/2005 | CN1675344A Oil or fat composition |
| 09/28/2005 | CN1675250A Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation |
| 09/28/2005 | CN1675249A Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 09/28/2005 | CN1675244A MCAM inhibitors |
| 09/28/2005 | CN1675229A Sulfur-containing phospholipid derivatives |
| 09/28/2005 | CN1675225A Macrocyclic pyrimidines, their production and use as pharmaceutical agents |
| 09/28/2005 | CN1675220A Epothilone derivatives |
| 09/28/2005 | CN1675214A Pyrimido compounds having antiproliferative activity |
| 09/28/2005 | CN1675213A 新的嘌呤衍生物 New purine derivatives |
| 09/28/2005 | CN1675211A 新的嘌呤衍生物 New purine derivatives |
| 09/28/2005 | CN1675209A Dihydropyrazolopyridine compounds |
| 09/28/2005 | CN1675208A Novel fused imidazole derivative |
| 09/28/2005 | CN1675203A Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 09/28/2005 | CN1675199A Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 09/28/2005 | CN1675197A 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 09/28/2005 | CN1675196A Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
| 09/28/2005 | CN1675195A Inhibitors of tyrosine kinases |
| 09/28/2005 | CN1675192A Novel compunds, pharmaceutical compositions containing same, and methods of use for same |
| 09/28/2005 | CN1675185A Therapeutic molecules and methods-1 |
| 09/28/2005 | CN1675184A Caspase inhibitors and uses thereof |
| 09/28/2005 | CN1675154A Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF) |
| 09/28/2005 | CN1674943A Radioactively labelled amino acid analogues, their preparation and use |
| 09/28/2005 | CN1674938A Combination of VEGF receptor tyrosine kinase inhibitors for treatment of cancer |
| 09/28/2005 | CN1674935A Biofunctional CpG or oligo-/polynucleotide and toxin or enterotoxin containing composition |
| 09/28/2005 | CN1674929A Use of protein kinase N beta |
| 09/28/2005 | CN1674927A Growth hormone releasing peptides |
| 09/28/2005 | CN1674922A Methods of treating angiogenesis, tumor growth, and metastasis |
| 09/28/2005 | CN1674921A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 09/28/2005 | CN1674918A Composition, formulations & kit for treatment of respiratory & lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s) |
| 09/28/2005 | CN1674917A Treatment of human multiple myeloma by curcumin |
| 09/28/2005 | CN1674908A Therapeutic combinations of erb B kinase inhibitors and antineoplastic therapies |
| 09/28/2005 | CN1674907A Use of reboxetine for the treatment of hot flashes |
| 09/28/2005 | CN1674906A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 09/28/2005 | CN1674905A Combination of ZD6474, an inhibitor of the vascular endothelial growth factor receptor, with radiotherapy in the treatment of cancer |
| 09/28/2005 | CN1674894A Ether substituted imidazopyridines |
| 09/28/2005 | CN1674891A Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue |
| 09/28/2005 | CN1674886A 软胶囊制剂 Soft capsule preparation |
| 09/28/2005 | CN1674883A Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 09/28/2005 | CN1674881A Drug composition containing NF-kappa B inhibitor |
| 09/28/2005 | CN1674795A Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 09/28/2005 | CN1673744A Treatment and diagnosis of cancer |
| 09/28/2005 | CN1673369A A novel APO and antibody thereof and preparation and use |
| 09/28/2005 | CN1673363A Pallas pit viper active hepatoenzyme |
| 09/28/2005 | CN1673352A A novel bacillus and separating process and application |
| 09/28/2005 | CN1673234A Schizo-octase alkyl glycoside compound and its prepn process |
| 09/28/2005 | CN1673230A Prepn of recombinant composite interferon-polyglycol conjugate and conjugate product |
| 09/28/2005 | CN1673226A Carboxylate medicine precursors of hydroxycamptothecine and its derivative and thei prepn and application |
| 09/28/2005 | CN1673225A Carbonate medicine precursors of hydroxycamptothecine and its derivative and their prepn and application |
| 09/28/2005 | CN1672732A Stable recombinant solid alpha-interferon composition |
| 09/28/2005 | CN1672725A Medicine for resisting inflammation, contracting uterus and eliminating tumor and its prepn process |
| 09/28/2005 | CN1672691A Prepn of squid ink extract and its application in making medicine and food for preventing and treating human tumor |
| 09/28/2005 | CN1672678A Separation and extraction of natural active long-chain fatty acid component for preventing and treating prostatosis and the prepn and application of its medicine prepn |
| 09/28/2005 | CN1672677A Grafted nano carbon and its suspension preparing process and medical use |
| 09/28/2005 | CN1220701C Recombinded chemotaxis cytokine of human cirumferential lymphatic tissue as well as its preparing method and use |
| 09/28/2005 | CN1220699C Polypeptide for inhibiting growth and migration of blood vessel endothelial cell and endothelial stem cell and its preparing method and use |
| 09/28/2005 | CN1220692C Process for preparing cephalotaxane derivatives |
| 09/28/2005 | CN1220684C 2, 4, Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 09/28/2005 | CN1220683C Acyl derivatives for treating VLA-4 related disorders |
| 09/28/2005 | CN1220519C Chinese medicinal composition for treating prostate cancer, its preparation method and its application in the preparation |
| 09/28/2005 | CN1220518C Chinese medicinal composition for anti-cancer and analgesia, its preparation method and its application |
| 09/28/2005 | CN1220516C Seabuckthora fruit and lucid ganoderma nutrition mixture with auxiliary anti-cancer function |
| 09/28/2005 | CN1220490C Use of piperazine oxirane derivatives in preparation of medicine for inducing death of neoplastic cells |
| 09/28/2005 | CN1220486C Beta -cyclodextrin of veratrum alcohol compound or its clathrate compound of derivative and its preparation |
| 09/27/2005 | US6949664 Acyclic unsaturated alcohols such as lipoxins, prepared by hydrogenation in the presence of lindlar's catalysts, for use as antiinflammmatory or antiproliferative agents |
| 09/27/2005 | US6949661 3-substituted-3-(substitutedsulfonyl or sulfanyl) pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase |
| 09/27/2005 | US6949647 Economically synthesis using narciclasine; epoxidation and reduction to diol; forming cyclic sulfate, ring opening with cesium benzoate and saponification |
| 09/27/2005 | US6949646 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases |